drug protocol number

AGB 002

drug sponsor

Archigen Biotech Limited

drug study

Rituximab/ SAIT101

drug trial site

Prince Sultan Military Medical City (Riyadh), King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase